Anti-tumor necrosis factor medications (anti-TNFs) were found to be effective in controlling chronic inflammatory diseases. Women can take anti-TNFs, as they appear to be safe during pregnancy.
In an Arthritis & Rheumatology analysis of 528 pregnancies of women exposed to certolizumab pegol (CZP), an anti-TNF approved for treatment of rheumatic diseases and/or Crohn's Disease, 85 percent of pregnancies resulted in live births, and the rate of major congenital malformations (2%) was similar to those reported for the general population in the United States and Europe.
New Treatment Route for Inflammatory Rheumatism is Now Open
The absence of anti-inflammatory protein A20 leads to a significant increase in a signalling molecule STAT1, which promotes the development of enthesitis.
Advertisement
‘Using Anti-tumor necrosis factor medications (anti-TNFs) during pregnancy can be safe for women with Crohn's Disease and rheumatoid arthritis.’
Tweet it Now
These findings are reassuring for women of childbearing age affected by chronic inflammatory diseases considering treatment with CZP who wish to become or are pregnant.
"In this large study of pregnancies, it appears that taking CZP during pregnancy did not increase the chances for pregnancy loss, preterm birth, or birth defects," said lead author Dr. Megan Clowse, of Duke University Medical Center.
"Continuing anti-TNFs in pregnancy has been recommended for many years for women with Crohn's Disease, and these data suggest that it is also safe for women with other inflammatory conditions, such as rheumatoid arthritis."
Source: Eurekalert
"Continuing anti-TNFs in pregnancy has been recommended for many years for women with Crohn's Disease, and these data suggest that it is also safe for women with other inflammatory conditions, such as rheumatoid arthritis."
Source: Eurekalert
AIDS Health Center Units To Offer Penicillin Shots For Rheumatic Heart Disease
Linking rheumatic heart disease services into existing HIV/AIDS clinics and primary health care centers can reduce the death rate of RHD.
Advertisement
 Scorpion Venom Reduces Severity of Rheumatoid ArthritisScorpion venom has compounds that block potassium channels and this property is used to reduce inflammation and pain in special cells that aggravate rheumatoid arthritis. | Advertisement
|
Biologics Do Not Increase The Risk of Second Malignancy
The concern for second malignancy or cancer recurrences in patients with history of cancer diagnosis has led to some reluctance in treating arthritis patients.
Advertisement
Recommended Readings
Latest Drug News
The impact of anti-obesity drugs on survival rates among osteoarthritis patients is under scrutiny, evaluating their potential influence on mortality risks.
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.